Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

NCT03008915 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Alpha-1 Antitrypsin Deficiency
Emphysema
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Aspirin
DRUG: Placebo
OTHER: Withdrawal from alpha1 antitrypsin replacement therapy

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]